| 000 | 01639 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514205542.0 | ||
| 264 | 0 | _c20041116 | |
| 008 | 200411s 0 0 eng d | ||
| 022 | _a0041-1337 | ||
| 024 | 7 |
_a10.1097/01.tp.0000137266.30134.02 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDenton, Mark D | |
| 245 | 0 | 0 |
_aTNP-470, an angiogenesis inhibitor, attenuates the development of allograft vasculopathy. _h[electronic resource] |
| 260 |
_bTransplantation _cOct 2004 |
||
| 300 |
_a1218-21 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAbdomen |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCoronary Disease _xetiology |
| 650 | 0 | 4 | _aCyclohexanes |
| 650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aGraft Survival _xdrug effects |
| 650 | 0 | 4 |
_aHeart Transplantation _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aO-(Chloroacetylcarbamoyl)fumagillol |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred F344 |
| 650 | 0 | 4 | _aRats, Inbred Lew |
| 650 | 0 | 4 |
_aSesquiterpenes _xadministration & dosage |
| 650 | 0 | 4 | _aTransplantation, Heterotopic |
| 700 | 1 | _aMagee, Colm | |
| 700 | 1 | _aMelter, Michael | |
| 700 | 1 | _aDharnidharka, Vikas R | |
| 700 | 1 | _aSayegh, Mohamed H | |
| 700 | 1 | _aBriscoe, David M | |
| 773 | 0 |
_tTransplantation _gvol. 78 _gno. 8 _gp. 1218-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.tp.0000137266.30134.02 _zAvailable from publisher's website |
| 999 |
_c15191913 _d15191913 |
||